The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia
NCT02858843
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
We were unable to enroll eligible subjects for the study.
Conditions
Cystic Fibrosis
Diabetes
Interventions
DRUG:
lumacaftor-ivacaftor
Sponsor
Massachusetts General Hospital